CannabisNewsWire
Editorial Coverage: Mainstream retailers across the United
States are embracing the growing popularity of the nonpsychoactive
cannabinoid, cannabidiol (CBD), making room for CBD products on
their prominent shelves.
With the rise of these cannabis beauty
products, major stores from luxury retailers Barney’s and Neiman
Marcus down to Walgreens, Rite Aid and now Kroger are stocking products from a range of CBD
SKU producers, including Green Growth Brands (CSE: GGB)
(OTCQB: GGBXF) (GGBXF
Profile), Charlotte’s Web Holdings (TSX: CWEB)
(OTCQX: CWBHF), CannTrust Holdings Inc. (TSX:
TRST) (NYSE: CTST), Organigram Holdings Inc.
(TSX.V: OGI) (NASDAQ: OGI) (OGI
Profile) and HEXO Corp. (TSX: HEXO) (NYSE
American: HEXO).
- Bridge-building companies strengthening bonds between retailers
and CBD producers.
- GGB has solidified several influential deals with top
companies.
- Cannabis beauty products could make multibillion-dollar impact
in the CBD sector.
To view an infographic of this editorial, click here.
Partnerships Key to CBD Growth
The bond between retailers and CBD producers seems to be growing
stronger by the month, ushered forward by bridge builders such as
Green Growth
Brands (CSE: GGB) (OTCQB: GGBXF), whose management
team’s CVs read like that of a mall directory, including
executive-level experience with major brands such as American Eagle
Outfitters, Abercrombie & Fitch, Bath & Body Works,
Victoria’s Secret, DSW, Luxottica and Virgin Entertainment.
These relationships have already resulted in GGB inking a series
of deals with major retailers, most recently with American Eagle
Outfitters. Starting in October 2019, the clothing retailer will be
carrying GGB’s hemp-derived, CBD-infused personal care products in
almost 500 physical stores as well as on the company website. These
products — which include lotions, muscle balms and aromatherapy
items — were developed exclusively for American Eagle.
Two weeks prior to the American Eagle announcement, GGB expanded
its partnership with Abercrombie &
Fitch to offer its Seventh Sense Botanical Therapy CBD products
through the iconic fashion brand. The growing popularity of CBD
products such as Seventh Sense has led analysts to increase their
targets on the cannabis industry as a whole.
Back in March, New York-based investment bank Cowen & Co.
put out a study on the CBD market, citing a $16 billion
target by 2025. BDS Analytics and Arcview Market Research gave
a more optimistic assessment, projecting that the collective market
for CBD sales in the
US will exceed $20 billion by 2024.
Welcoming the CBD Retail Revolution
Perhaps the most impactful addition to the CBD sector is the
rise of “cannabis beauty.” Analysts at Piper Jaffray believe the
cannabis beauty wave could potentially boost the overall CBD market to between $50 billion to $100 billion.
In July, American Eagle agreed to stock the shelves of nearly
500 stores with Green Growth Brands’ tailor-made, CBD-infused
personal care products. The new line of products will be available
as early as October and will be available for purchase online as
well.
In late June, fashionable brand Abercrombie & Fitch expanded
its partnership with Green Growth Brands to sell Seventh Sense
Botanical Therapy products in more than 160 A&F stores. After a
retail trial in 10 stores, the increase in exposure is expected to
be mutually beneficial as A&F carries Seventh Sense’s
CBD-infused body lotions, muscle balms, lip balms and sugar
scrubs.
The American Eagle and A&F placements supplemented the
string of partnerships Green Growth Brands has secured so far in
2019, which began with a
partnership with DSW Inc. to sell Seventh Sense in 96
U.S.-based DSW stores. GGB also signed a licensing agreement with
Authentic Brands Group and the Greg Norman brand to develop CBD
personal care products for active adult men and women.
With its management team’s impressive retail experience, much of
which is centered around prominent space in malls, GGB has
aggressively launched its own Seventh Sense stores and kiosks
across the country. In just the first four months after launch,
over 50 Seventh Sense stores had been opened by
June.
GGB’s goal is to have
approximately 70 stores opened by the end of 2019. Given the
company’s seemingly advantageous deals with major mall chain owners
such as Brookfield Properties, Simon Property Group, and a series
of independent malls, it appears likely the company will hit this
target.
In a recent interview
with Jim Cramer, CNBC host of Mad Money, GGB CEO Peter
Horvath confidently reiterated his company’s strategy that plays
off its retail expertise, and in particular the potential of CBD,
specifically topical products. Harvath noted that the partnerships
in place mean that GGB stores are opening in prime locations in
some of the country’s best malls.
Developments in the CBD Upswing
This potential isn’t being missed by other CBD innovators in the
market.
Early pioneers in the CBD space, Charlotte’s Web
Holdings (TSX: CWEB) (OTCQX: CWBHF) now manufactures and
markets CBD wellness products, including capsules, topicals and
gels in more than 3,000 retail locations across the country. Named
after a little girl named Charlotte who suffered from up to 300
grand mal seizures per week, the company is focused on what ended
up being a cure for her malady — CBD. The brothers who manufactured
the strain that helped Charlotte went on to found Charlotte’s Web
in 2013. As recently as
December 2018, CWEB products were available in 3,680 retail
locations. That number has since exploded to
6,000.
CannTrust Holdings Inc. (TSX: TRST) (NYSE:
CTST) increased its portfolio by expanding its CBD product
lines with the addition of three new products: high-dose CBD oil
capsules and a low-dose and high-dose version of CBD drops. In
addition, the company recently announced plans to enter the U.S.
CBD market, starting with a hemp-production
joint venture in California. As part of the deal, CannTrust
plans to cultivate upwards of 3,000 acres of hemp for CBD in
California. CannTrust continues to develop its lines of innovative
products, including CBD beverages, pet-care products and
confectionaries.
North of the border, East Coast Canadian company
Organigram
Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) is developing
a nano-emulsion technique to help cannabinoids such as CBD to
dissolve in water, which isn’t done naturally. Organigram has
recently developed an emulsification system to turn cannabinoids
into a dissolvable powder, making CBD more shelf stable, thermally
stable, water compatible and palatable. Focusing outside of the
United States and its home jurisdiction of Canada, Organigram
Holdings Inc. is making a play to jump the pond into what’s being
touted as a lucrative EU CBD market. Teaming with
Alpha-cannabis, Organigram has its sights set on the German
medical cannabis market, while also partnering with Eviana to
obtain hemp-derived CBD to supply into key EU markets.
HEXO Corp. (TSX: HEXO) (NYSE American: HEXO) is
also in the development of beverages through its partnership deal with Molson Coors. Aligned with the
Canadian brewing giant, HEXO is gearing up for cannabinoid-infused
beverages that could one day be sold in the refrigerated aisle of
the local grocer. HEXO also recently outlined plans to enter eight U.S. states with CBD products — but not
until 2020. The company wouldn’t say which states it is targeting,
but expectations are that it will make the move through its joint
venture with Molson Coors, which includes plans to co-launch a
portfolio of cannabis-infused beverages called Truss.
Key relationships and a promising cannabis beauty space bode
well for continued strong growth in the CBD sector. Companies such
as Green Growth Brands appear well positioned to take advantage of
these opportunities.
For a free research report on Green Growth Brands, visit
PotStockNews.com
For more information on Green Growth Brands, visit Green Growth
Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides
(1) access to our news aggregation and syndication servers, (2)
CannabisNewsBreaks that summarize
corporate news and information, (3) enhanced press release
services, (4) social media distribution and optimization services,
and (5) a full array of corporate communication solutions. As a
multifaceted financial news and content distribution company with
an extensive team of contributing journalists and writers, CNW is
uniquely positioned to best serve private and public companies that
desire to reach a wide audience of investors, consumers,
journalists and the general public. CNW has an ever-growing
distribution network of more than 5,000 key syndication outlets
across the country. By cutting through the overload of information
in today’s market, CNW brings its clients unparalleled visibility,
recognition and brand awareness. CNW is where news, content and
information converge.
Receive Text Alerts
from CannabisNewsWire: Text "Cannabis" to
21000
For more information please visit https://www.CannabisNewsWire.com and
or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the
CannabisNewsWire website applicable to all content provided by CNW,
wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article
and content set forth above. References to any issuer other than
the profiled issuer are intended solely to identify industry
participants and do not constitute an endorsement of any issuer and
do not constitute a comparison to the profiled issuer. The
commentary, views and opinions expressed in this release by CNW are
solely those of CNW. Readers of this Article and content agree that
they cannot and will not seek to hold liable CNW for any investment
decisions by their readers or subscribers. CNW is a news
dissemination and financial marketing solutions provider and is NOT
registered broker-dealers/analysts/investment advisers, hold no
investment licenses and may NOT sell, offer to sell or offer to buy
any security.
The Article and content related to the profiled company
represent the personal and subjective views of the Author, and are
subject to change at any time without notice. The information
provided in the Article and the content has been obtained from
sources which the Author believes to be reliable. However, the
Author has not independently verified or otherwise investigated all
such information. None of the Author, CNW, or any of their
respective affiliates, guarantee the accuracy or completeness of
any such information. This Article and content are not, and should
not be regarded as investment advice or as a recommendation
regarding any particular security or course of action; readers are
strongly urged to speak with their own investment advisor and
review all of the profiled issuer’s filings made with the
Securities and Exchange Commission before making any investment
decisions and should understand the risks associated with an
investment in the profiled issuer’s securities, including, but not
limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. “Forward-looking statements” describe future expectations,
plans, results, or strategies and are generally preceded by words
such as “may”, “future”, “plan” or “planned”, “will” or “should”,
“expected,” “anticipates”, “draft”, “eventually” or “projected”.
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company’s annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and CNW undertakes no
obligation to update such statements.
Source:
CannabisNewsWire
Contact:
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net
Charlottes Web (QX) (USOTC:CWBHF)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
Charlottes Web (QX) (USOTC:CWBHF)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025
